Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and thienopyrimidine

quinazolines has been researched along with thienopyrimidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caferro, TR; Dickerson, SH; Donaldson, KH; Gaul, MD; Goetz, AS; McDonald, OB; Mullin, RJ; Petrov, KG; Rheault, TR; Rusnak, DW; Shewchuk, LM; Spehar, GM; Truesdale, AT; Uehling, DE; Vanderwall, DE; Wood, ER1
de la Haye, A; Gütschow, M; Häcker, HG; Schnakenburg, G; Sterz, K; Wiese, M1
Chun, K; Han, G; Joe, BY; Kang, JS; Kim, H; Kim, HY; Kim, MH; Lee, C; Lee, JI; Park, CH; Yang, JS1
Cagnotto, A; Intagliata, S; Modica, MN; Pittalà, V; Romeo, G; Salerno, L; Salmona, M; Siracusa, MA1
Furuya, M; Iwaki, T; Iwamoto, O; Kawase, Y; Nagayama, T; Nakamura, Y; Ogawa, Y; Okamura, Y; Oyama, Y; Tanaka, T1

Other Studies

5 other study(ies) available for quinazolines and thienopyrimidine

ArticleYear
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors.
    Bioorganic & medicinal chemistry letters, 2009, Feb-01, Volume: 19, Issue:3

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Humans; Inhibitory Concentration 50; Lapatinib; Models, Chemical; Molecular Conformation; Pyrimidines; Quinazolines; Receptor, ErbB-2

2009
Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity.
    Bioorganic & medicinal chemistry letters, 2009, Nov-01, Volume: 19, Issue:21

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Crystallography, X-Ray; Daunorubicin; Drug Resistance, Neoplasm; Humans; Molecular Conformation; Pyrimidines; Quinazolines; Substrate Specificity

2009
Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKβ inhibitors.
    Bioorganic & medicinal chemistry letters, 2014, Jun-15, Volume: 24, Issue:12

    Topics: Enzyme Activation; fms-Like Tyrosine Kinase 3; Humans; I-kappa B Kinase; Maleimides; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Small Molecule Libraries

2014
Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.
    Bioorganic & medicinal chemistry letters, 2015, Apr-01, Volume: 25, Issue:7

    Topics: Binding Sites; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Piperazine; Piperazines; Pyrimidines; Quinazolines; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Structure-Activity Relationship

2015
Discovery and SAR of a novel series of Natriuretic Peptide Receptor-A (NPR-A) agonists.
    Bioorganic & medicinal chemistry letters, 2017, 11-01, Volume: 27, Issue:21

    Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Humans; Pyrimidines; Quinazolines; Receptors, Atrial Natriuretic Factor; Structure-Activity Relationship

2017